StonvexLoading…
StonvexStonvexStonvexCore line items from PRTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $953.01M | $879.70M | $755.61M | $663.64M |
Operating Income | $141.25M | $133.42M | $81.52M | $56.16M |
Net Income | $55.68M | $24.02M | $-1.31M | $-2.15M |
EPS (Diluted) | $0.68 | $-0.31 | $-0.63 | $-0.50 |
Total Assets | $2.40B | $1.83B | $1.62B | $1.37B |
Total Liabilities | $2.49B | $1.99B | $1.50B | $1.24B |
Cash & Equivalents | $77.19M | $58.60M | $39.60M | $18.45M |
Free Cash Flow OCF − CapEx | $75.08M | $63.92M | $60.00M | $51.64M |
Shares Outstanding | 81.91M | 77.48M | 76.96M | 76.04M |